Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
0.00
0.00 (0.00%)
May 12, 2026, 1:58 PM EDT - Market open
Bio-Rad Laboratories Market Cap
Bio-Rad Laboratories has a market cap or net worth of $6.58 billion as of May 12, 2026. Its market cap has decreased by -0.34% in one year.
Market Cap
6.58B
Enterprise Value
6.40B
1-Year Change
-0.34%
Ranking
Category
Stock Price
n/a
Market Cap Chart
Since May 12, 2021, Bio-Rad Laboratories's market cap has decreased from $17.38B to $6.58B, a decrease of -62.12%. That is a compound annual growth rate of -17.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 6.68B | -18.09% |
| Dec 31, 2025 | 8.16B | -11.13% |
| Dec 31, 2024 | 9.18B | -1.27% |
| Dec 29, 2023 | 9.30B | -25.52% |
| Dec 30, 2022 | 12.48B | -44.81% |
| Dec 31, 2021 | 22.62B | 30.13% |
| May 12, 2021 | 17.38B | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Smith & Nephew | 12.72B |
| Penumbra | 12.67B |
| Insulet | 10.68B |
| Globus Medical | 10.58B |
| Masimo | 9.34B |
| Glaukos | 7.84B |
| Bio-Rad Laboratories | 6.81B |
| Bruker | 6.72B |